Literature DB >> 16709183

TSG-6: a pluripotent inflammatory mediator?

C M Milner1, V A Higman, A J Day.   

Abstract

TSG-6 is a multifunctional protein that is up-regulated in many pathological and physiological contexts, where it plays important roles in inflammation and tissue remodelling. For example, it is a potent inhibitor of neutrophil migration and can modulate the protease network through inhibition of plasmin. TSG-6 binds a wide range of GAGs (glycosaminoglycans) [i.e. HA (hyaluronan), chondroitin 4-sulphate, dermatan sulphate, heparin and heparan sulphate] as well as a variety of protein ligands, where these interactions can influence the activities of TSG-6. For example, through its association with HA, TSG-6 can mediate HA cross-linking via several different mechanisms, some of which promote leucocyte adhesion. Binding to heparin, however, enhances the ability of TSG-6 to potentiate the anti-plasmin activity of inter-alpha-inhibitor, which binds non-covalently to TSG-6 via its bikunin chain. Furthermore, although HA and heparin interact with distinct sites on the Link module, the binding of heparin can inhibit subsequent interaction with HA. In addition, the interactions of TSG-6 with HA, heparin and at least some of its protein ligands are sensitive to pH. Therefore it seems that in different tissue micro-environments (characterized, for example, by pH and GAG content), TSG-6 could be partitioned into functional pools with distinct activities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709183     DOI: 10.1042/BST0340446

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  103 in total

1.  Lactobacillus paracasei and Lactobacillus plantarum strains downregulate proinflammatory genes in an ex vivo system of cultured human colonic mucosa.

Authors:  Christine Bäuerl; Marta Llopis; María Antolín; Vicente Monedero; Manuel Mata; Manuel Zúñiga; Francisco Guarner; Gaspar Pérez Martínez
Journal:  Genes Nutr       Date:  2012-06-06       Impact factor: 5.523

Review 2.  Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain.

Authors:  Hiroshi Shigetomi; Akira Onogi; Hirotaka Kajiwara; Shozo Yoshida; Naoto Furukawa; Shoji Haruta; Yasuhito Tanase; Seiji Kanayama; Taketoshi Noguchi; Yoshihiko Yamada; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Inflamm Res       Date:  2010-05-08       Impact factor: 4.575

3.  Nuclear Magnetic Resonance Insight into the Multiple Glycosaminoglycan Binding Modes of the Link Module from Human TSG-6.

Authors:  Younghee Park; Thomas A Jowitt; Anthony J Day; James H Prestegard
Journal:  Biochemistry       Date:  2016-01-06       Impact factor: 3.162

Review 4.  Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation.

Authors:  Darwin J Prockop; Joo Youn Oh
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

5.  Mesenchymal stem cell therapy: Two steps forward, one step back.

Authors:  James Ankrum; Jeffrey M Karp
Journal:  Trends Mol Med       Date:  2010-03-23       Impact factor: 11.951

6.  TSG-6 potentiates the antitissue kallikrein activity of inter-alpha-inhibitor through bikunin release.

Authors:  Rosanna Forteza; Susana M Casalino-Matsuda; Maria Elena Monzon; Erik Fries; Marilyn S Rugg; Caroline M Milner; Anthony J Day
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-27       Impact factor: 6.914

7.  TSG-6 is highly expressed in human abdominal aortic aneurysms.

Authors:  S Keisin Wang; Jie Xie; Linden A Green; Robert A McCready; Raghu L Motaganahalli; Andres Fajardo; Clifford C Babbey; Michael P Murphy
Journal:  J Surg Res       Date:  2017-08-12       Impact factor: 2.192

8.  Acute and temporal expression of tumor necrosis factor (TNF)-α-stimulated gene 6 product, TSG6, in mesenchymal stem cells creates microenvironments required for their successful transplantation into muscle tissue.

Authors:  Shigeko Torihashi; Mioko Ho; Yuji Kawakubo; Kazumi Komatsu; Masataka Nagai; Yuri Hirayama; Yuka Kawabata; Nana Takenaka-Ninagawa; Orawan Wanachewin; Lisheng Zhuo; Koji Kimata
Journal:  J Biol Chem       Date:  2015-07-15       Impact factor: 5.157

Review 9.  Stem cell therapy for type 1 diabetes mellitus.

Authors:  Cristina Aguayo-Mazzucato; Susan Bonner-Weir
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

10.  TSG-6 transfers proteins between glycosaminoglycans via a Ser28-mediated covalent catalytic mechanism.

Authors:  Kristian W Sanggaard; Carsten S Sonne-Schmidt; Toke P Krogager; Torsten Kristensen; Hans-Georg Wisniewski; Ida B Thøgersen; Jan J Enghild
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.